HomeCAPR • NASDAQ
add
Capricor Therapeutics Inc
Previous close
$33.42
Day range
$29.41 - $33.00
Year range
$4.30 - $40.37
Market cap
1.39B USD
Avg Volume
1.29M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.02M | 40.99% |
Net income | -30.17M | -323.95% |
Net profit margin | — | — |
Earnings per share | -0.62 | -287.50% |
EBITDA | -28.66M | -291.46% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 98.57M | -34.95% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 83.87M | — |
Shares outstanding | 57.37M | — |
Price to book | — | — |
Return on assets | — | — |
Return on capital | -74.07% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -30.17M | -323.95% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2005
Website
Employees
160
